These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2451859

  • 1. Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man.
    Björk P, Axelsson L, Bergenfeldt M, Ohlsson K.
    Scand J Clin Lab Invest; 1988 Apr; 48(2):205-11. PubMed ID: 2451859
    [Abstract] [Full Text] [Related]

  • 2. Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
    Håkansson HO, Ohlsson K.
    Gastroenterol Jpn; 1992 Oct; 27(5):652-6. PubMed ID: 1358738
    [Abstract] [Full Text] [Related]

  • 3. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
    Fryksmark U, Ohlsson K, Rosengren M, Tegner H.
    Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):793-800. PubMed ID: 6194094
    [Abstract] [Full Text] [Related]

  • 4. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
    Lasson A, Ohlsson K.
    Biochim Biophys Acta; 1982 Dec 20; 709(2):227-33. PubMed ID: 6185150
    [Abstract] [Full Text] [Related]

  • 5. Influence of the human pancreatic secretory trypsin inhibitor on trypsin-induced C3 and kininogen cleavage: an in vitro study.
    Ohlsson K.
    Scand J Gastroenterol Suppl; 1986 Dec 20; 126():18-20. PubMed ID: 2436281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proteases and antiproteases related to the coagulation system in plasma and ascites--an approach to differentiate between malignant and cirrhotic ascites.
    Schölmerich J, Zimmermann U, Köttgen E, Volk BA, Ehlers S, Gerok W.
    Klin Wochenschr; 1987 Jul 15; 65(14):634-8. PubMed ID: 2442449
    [Abstract] [Full Text] [Related]

  • 9. Human monocytes release plasma serine protease inhibitors in vitro.
    Kłoczko J, Bielawiec M, Giedrojć J, Radziwon P, Galar M.
    Haemostasis; 1990 Jul 15; 20(4):229-32. PubMed ID: 1700759
    [Abstract] [Full Text] [Related]

  • 10. Improved prognosis of fulminant hepatic failure (FHF) after plasma derivative replacement therapy. Enhanced proteolysis of hemostatic proteins confirmed by proteinase-inhibitor complexes determination.
    Egbring R, Seitz R.
    Z Gastroenterol; 1990 Feb 15; 28(2):104-9. PubMed ID: 2138832
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH.
    J Lab Clin Med; 1994 Jul 15; 124(1):118-24. PubMed ID: 7518491
    [Abstract] [Full Text] [Related]

  • 12. Interactions in vitro and in vivo between human and porcine cationic pancreatic elastase and plasma protease inhibitors.
    Håkansson HO, Ohlsson K.
    Biol Chem Hoppe Seyler; 1988 Apr 15; 369(4):309-15. PubMed ID: 2456771
    [Abstract] [Full Text] [Related]

  • 13. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors.
    Kolev K, Komorowicz E, Machovich R.
    Blood Coagul Fibrinolysis; 1994 Dec 15; 5(6):905-11. PubMed ID: 7534486
    [Abstract] [Full Text] [Related]

  • 14. Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats.
    Kruse P, Hage E, Lasson A.
    Int J Pancreatol; 1999 Apr 15; 25(2):113-21. PubMed ID: 10360224
    [Abstract] [Full Text] [Related]

  • 15. Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.
    Bergenfeldt M, Ohlsson K.
    Gastroenterol Jpn; 1993 Oct 15; 28(5):687-98. PubMed ID: 8224620
    [Abstract] [Full Text] [Related]

  • 16. Components of the kallikrein-kinin-system in patients with ARDS.
    Fuhrer G, Heller W, Junginger W, Gröber O, Roth K.
    Prog Clin Biol Res; 1989 Oct 15; 308():737-42. PubMed ID: 2476827
    [No Abstract] [Full Text] [Related]

  • 17. Determination of functional activity of alpha 1-protease inhibitor and alpha 2-macroglobulin in human plasma using elastase.
    Gaillard MC, Kilroe-Smith TA.
    J Clin Chem Clin Biochem; 1987 Mar 15; 25(3):167-72. PubMed ID: 2439646
    [Abstract] [Full Text] [Related]

  • 18. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A, Ohlsson K.
    Adv Exp Med Biol; 1984 Mar 15; 167():477-87. PubMed ID: 6201050
    [Abstract] [Full Text] [Related]

  • 19. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
    Kruse P, Lasson A, Hage E.
    J Surg Res; 1999 Aug 15; 85(2):294-300. PubMed ID: 10423332
    [Abstract] [Full Text] [Related]

  • 20. Quantitation of human leukocyte elastase, cathepsin G, alpha-2-macroglobulin and alpha-1-proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids.
    Virca GD, Mallya RK, Pepys MB, Schnebli HP.
    Adv Exp Med Biol; 1984 Aug 15; 167():345-53. PubMed ID: 6201046
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.